488 related articles for article (PubMed ID: 25947025)
1. [A case of secondary sclerosing cholangitis caused by chemotherapy with nab-paclitaxel].
Matsuo T; Nakamura Y; Suzuki K
Nihon Shokakibyo Gakkai Zasshi; 2015 May; 112(5):888-95. PubMed ID: 25947025
[TBL] [Abstract][Full Text] [Related]
2. Secondary sclerosing cholangitis after chemotherapy with bevacizumab and paclitaxel.
von Figura G; Stephani J; Wagner M; Wegener M; Wolf C; Adler G; Kulaksiz H
Endoscopy; 2009; 41 Suppl 2():E153-4. PubMed ID: 19544276
[No Abstract] [Full Text] [Related]
3. Nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as second-line chemotherapy in HER2-negative, taxane-pretreated metastatic breast cancer patients: prospective evaluation of activity, safety, and quality of life.
Palumbo R; Sottotetti F; Trifirò G; Piazza E; Ferzi A; Gambaro A; Spinapolice EG; Pozzi E; Tagliaferri B; Teragni C; Bernardo A
Drug Des Devel Ther; 2015; 9():2189-99. PubMed ID: 25931813
[TBL] [Abstract][Full Text] [Related]
4. Quality-Adjusted Survival With nab-Paclitaxel Versus Standard Paclitaxel in Metastatic Breast Cancer: A Q-TWiST Analysis.
Cortes J; Pérez-García J; Whiting S; Wan Y; Solem C; Tai MH; Margunato-Debay S; Ko A; Fandi A; Botteman M
Clin Breast Cancer; 2018 Oct; 18(5):e919-e926. PubMed ID: 29703690
[TBL] [Abstract][Full Text] [Related]
5. Nab-paclitaxel-induced cystoid macular edema in a patient with pre-existing optic neuropathy.
Park E; Goldberg NR; Adams S
Anticancer Drugs; 2016 Jul; 27(6):580-4. PubMed ID: 26982237
[TBL] [Abstract][Full Text] [Related]
6. Secondary sclerosing cholangitis induced by systemic chemotherapy.
Antón Rodriguez Á; Odriozola Herrán A; Echavarría Rodríguez VJ; Alonso Fernández S
Rev Esp Enferm Dig; 2024 Mar; 116(3):173-174. PubMed ID: 37170638
[TBL] [Abstract][Full Text] [Related]
7. Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial.
Shitara K; Takashima A; Fujitani K; Koeda K; Hara H; Nakayama N; Hironaka S; Nishikawa K; Makari Y; Amagai K; Ueda S; Yoshida K; Shimodaira H; Nishina T; Tsuda M; Kurokawa Y; Tamura T; Sasaki Y; Morita S; Koizumi W
Lancet Gastroenterol Hepatol; 2017 Apr; 2(4):277-287. PubMed ID: 28404157
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticle albumin-bound paclitaxel (nab-paclitaxel): extending its indications.
Kudlowitz D; Muggia F
Expert Opin Drug Saf; 2014 Jun; 13(6):681-5. PubMed ID: 24749649
[No Abstract] [Full Text] [Related]
9. [A Case of a Corneal Disorder after Breast Cancer Treatment with Nab-paclitaxel].
Hosotani Y; Morimatsu T; Takata M; Mimura O
Nippon Ganka Gakkai Zasshi; 2016 Jun; 120(6):449-53. PubMed ID: 27487717
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy and tolerability of controlled-release oxycodone against nab-paclitaxel-induced musculoskeletal pain in breast cancer patients].
Inoue K; Ohkubo F; Nagai S; Tsuboi M; Kubo K; Kurozumi K; Hayashi Y; Matsumoto H; Takei H
Gan To Kagaku Ryoho; 2013 Aug; 40(8):1021-5. PubMed ID: 23986044
[TBL] [Abstract][Full Text] [Related]
11. [Clinical experience of nab-Paclitaxel treatment in 31 patients with breast cancer].
Tauchi Y; Kashiwagi S; Ishihara S; Asano Y; Sakimura C; Kurata K; Tokumoto M; Morisaki T; Noda S; Kawajiri H; Takashima T; Onoda N; Hirakawa K
Gan To Kagaku Ryoho; 2014 Nov; 41(12):1948-50. PubMed ID: 25731385
[TBL] [Abstract][Full Text] [Related]
12. [A case of sclerosing cholangitis caused by oral chemotherapy with S-1].
Morisaki T; Ohnita K; Takeshima F; Akazawa Y; Yamaguchi N; Miyaaki H; Taura N; Ichikawa T; Isomoto H; Toriyama H; Nakao K
Nihon Shokakibyo Gakkai Zasshi; 2011 Feb; 108(2):245-52. PubMed ID: 21307629
[TBL] [Abstract][Full Text] [Related]
13. [Administration of nab-paclitaxel for 9 metastatic breast cancer patients].
Sakaguchi K; Mizuta N; Imai A; Nakatsukasa K; Morita M; Soushi M; Taguchi T
Gan To Kagaku Ryoho; 2012 Jul; 39(7):1081-5. PubMed ID: 22790043
[TBL] [Abstract][Full Text] [Related]
14. Cystoid macular edema without leakage secondary to nab-Paclitaxel (Abraxane): clinical experience with intravitreal bevacizumab.
Rahman HT; Yeh S; Bergstrom CS
J Ocul Pharmacol Ther; 2013 Apr; 29(3):360-2. PubMed ID: 23061416
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of supportive care for albumin-bound paclitaxel(nab-paclitaxel)in 20 patients with metastatic breast cancer].
Yamada C; Yonezawa M; Shimizu Y; Taga R; Kashihara H; Tsuji K; Murata T; Yoshino H
Gan To Kagaku Ryoho; 2014 Jan; 41(1):77-81. PubMed ID: 24423956
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy analysis by histology of weekly nab-paclitaxel in combination with carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer.
Socinski MA; Okamoto I; Hon JK; Hirsh V; Dakhil SR; Page RD; Orsini J; Yamamoto N; Zhang H; Renschler MF
Ann Oncol; 2013 Sep; 24(9):2390-6. PubMed ID: 23842283
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Chemotherapy Following Anti-PD-1 Antibody Therapy for Gastric Cancer: A Case of Sclerosing Cholangitis.
Kono M; Sakurai T; Okamoto K; Masaki S; Nagai T; Komeda Y; Kamata K; Minaga K; Yamao K; Takenaka M; Watanabe T; Nishida N; Kudo M
Intern Med; 2019 May; 58(9):1263-1266. PubMed ID: 30626829
[TBL] [Abstract][Full Text] [Related]
18. Treatment of recurrent and platinum-refractory stage IV non-small cell lung cancer with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as a single agent.
Saxena A; Schneider BJ; Christos PJ; Audibert LF; Cagney JM; Scheff RJ
Med Oncol; 2016 Feb; 33(2):13. PubMed ID: 26749586
[TBL] [Abstract][Full Text] [Related]
19. [Outcome and Problems of Nab-Paclitaxel Therapy for Gastric Cancer in Clinical Practice].
Doi T; Ishikawa T; Okayama T; Dohi O; Yoshida N; Kamada K; Katada K; Sogame Y; Uchiyama K; Handa O; Takagi T; Yasuda H; Sakagami J; Konishi H; Naito Y; Itoh Y
Gan To Kagaku Ryoho; 2016 Feb; 43(2):211-4. PubMed ID: 27067684
[TBL] [Abstract][Full Text] [Related]
20. Nab-paclitaxel for breast cancer: a new formulation with an improved safety profile and greater efficacy.
Henderson IC; Bhatia V
Expert Rev Anticancer Ther; 2007 Jul; 7(7):919-43. PubMed ID: 17627452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
